Abstract:Objective Research the intervention effect of total flavonoid of Pteris multifida in benign prostatic hyperplasia(BPH) castrated rats and the possible mechanism.Methods Removing of bilateral testes in SD rats,and subcutaneous injecting of testosterone propionate,established castrated rat model of benign prostatic hyperplasia.After the success of modeling,The model rats were randomly divided into 6 groups,the blank control group,model group,total flavonoid of Pteris multifida group (high,medium,low dose group),positive drug group (dutasteride group,prostat group),were fed with relevant drugs respectively,blank control group and model group were fed with the same volume of distilled water.Every group was given daily administration and consecutive for 45 days,then weighed the prostate and calculated the prostatic index (PI),measured the level of serum testosterone (T),dihyrotestotestosterone (DHT),estradiol (E2).Observe the pathological changes at the prostate tissue under the light microscope,observe the ultrastructural changes of prostate cells under the electron microscope.Results Total flavonoid of Pteris multifida can reduce the prostate wet weight and PI,Compared with rats in the BPH model group [(2.284 ±0.241) g,(0.586 ±0.100)％],total flavonoid of Pteris multifida treated groups had remarkably lower prostate wet weight [(1.750 ± 0.245),(1.998 0.328),(2.064 ± 0.196) g] and PI [(0.440 ± 0.069),(0.481 ± 0.085),(0.519 ± 0.063) ％],except the PI of low dose group,the difference between groups was statistically significant (P ＜ 0.05).The levels of T,E2 and DHT were determined via enzyme linked immunosorbent assay (ELISA).Compared with rats in the BPH model group [(0.21-±0.02) μg/L,(18.4 ± 1.65) ng/L),total flavonoid of Pteris multifida high dose treated group had remarkably lower T and DHT levels [(0.18 ±0.01) μg/L,(16.3 ± 1.61) ng/L],however and the ratio of E2/T in high dose group (7.24 ± 0.63) had increased compared with rats in the BPH model group (6.53 ± 0.35),the difference between groups was statistically significant (P ＜ 0.05).The pathological manifestations improved with various degrees.Observation with electron microscopic each dose group of total flavonoid of Pteris multifida showed low columnar epithelial cells,the nucleolus fiat,nucleus atrophy and apoptosis.Conclusion This study showed that subcutaneous injection of testosterone propionate could replicate of the model of BPH in rats successful.The total flavonoids of Pteris multifida could significantly reduce the prostate wet weight and PI.The mechanism might be total flavonoid of Pteris multifida could reduce T and DHT levels,increase E2/T ratio.maintain the estrogen and androgen in relative balance along with promote the apoptosis and regulate the cell cycle,so as to the treatment effect of inhibiting hyperplasia.

Intervention Study of Prostata Plex on Benign Prostatic Hyperplasia

Saw Palmetto-Based Nutritional Supplement Prostataplex Relieves Symptoms of Benign Prostatic Hyperplasia (BPH) in Patients with Mild to Moderate BPH

Effect of Transurethral Feedback Microwave Thermotherapy in High Risk Patients with Benign Prostate Hyperplasia

Pharmacoeconomic Evaluation of Tamsulosin Hydrochloride Sustained-release Capsules in the Treatment of Benign Prostatic Hyperplasia

A Randomized Placebo-Controlled Study: Phellodendron Bawei Tablets Combined with Standard Management Can Improve Storage Symptoms, Sleep Quality, and Medication Compliance in Patients with Benign Prostatic Hyperplasia Compared to Placebo with Standard Management.

The Efficacy and Safety of ProstantTM in the Treatment of Chronic Prostatitis:A Multi Center, Randomized, Double Blinded, Placebo Controlled Trial

Effect of Self-Management on Lower Urinary Tract Symptoms and Life Quality of Benign Prostatic Hyperplasia Patients

[Cost and Effectiveness Analysis of Treatments for Benign Prostatic Hyperplasia].

Therapeutic Effect of Harnal and Proscar in Treating Benign Prostatic Hyperplasia

IMPACT OF INTERVENTIONAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA ON QUALITY OF LIFE AND SEXUAL FUNCTION: A PROSPECTIVE STUDY

Evaluation on Safety and Efficacy of Finasteride in Treatment of Benign Prostatic Hyperplasia

[A Multi-Center Clinical Trial of Qianlieantong Tablets for Chronic Prostatitis].

Intervention Effect and Mechanism Research of Total Flavonoid of Pteris Multifida in Benign Prostatic Hyperplasia Rats

Observation on Curative Efficacy of Tamsulosin Hydrochloride Sustained-Release Capsules Combined with Finasteride Tablets in the Treatment of Benign Prostatic Hyperplasia

Clinical observation of Qianlie Shutong Capsules combined with finasteride in treatment of benign prostatic hyperplasia

Efficacy and Safety of a Bfgf Inhibitor, Tadenan in the Treatment of Benign Prostatic Hyperplasia: a Multicenter Trial in China

Combined low-frequency ultrasound and microbubble contrast agent for the treatment of benign prostatic hyperplasia.

Combination Therapy with Curcumin Plus Tamsulosin and Finasteride in the Treatment of Men with Benign Prostatic Hyperplasia: a Single Center, Randomized Control Study

Improvement of Erectile Function in Patients with Benign Prostatic Hyperplasia Undergoing Transurethral Plasmakinetic Resection of the Prostate.

[Clinical Study of Eviprostat for the Treatment of Benign Prostatic Hyperplasia].

Effectiveness of combined therapy with terazosin and tolterodine for patients with benign prostatic hyperplasia